The Ledger

MET

Metlife IncFinancialsinsider_universe

Last close $97.33Sep 13, 2026

Day +0.20%

Currently held

options_momentumlong
1 contracts · CALL $89 exp Aug 6, 2026 · entry $3.31
+$55.83 unrealized

Everything we've seen

·Sep 14, 3:17 PMstreamnews
Higher Rates Are a Gift to These 3 Insurance Dividend Stocks
Insurance companies collect your premiums today and settle your claims years from now, and that gap is quietly becoming a profit engine as rates stay elevated. Three insurers are turning this float mechanic into dividend growth that outlasted a pandemic, an inflation shock, and back-to-back catastrophe years.
·Sep 14, 3:02 PMstreamnews
Higher Rates Are a Gift to These 3 Insurance Dividend Stocks
Insurance companies collect your premiums today and settle your claims years from now, and that gap is quietly becoming a profit engine as rates stay elevated. Three insurers are turning this float mechanic into dividend growth that outlasted a pandemic, an inflation shock, and back-to-back catastrophe years.
·Sep 14, 2:47 PMstreamnews
Higher Rates Are a Gift to These 3 Insurance Dividend Stocks
Insurance companies collect your premiums today and settle your claims years from now, and that gap is quietly becoming a profit engine as rates stay elevated. Three insurers are turning this float mechanic into dividend growth that outlasted a pandemic, an inflation shock, and back-to-back catastrophe years.
·Sep 14, 2:32 PMstreamnews
Higher Rates Are a Gift to These 3 Insurance Dividend Stocks
Insurance companies collect your premiums today and settle your claims years from now, and that gap is quietly becoming a profit engine as rates stay elevated. Three insurers are turning this float mechanic into dividend growth that outlasted a pandemic, an inflation shock, and back-to-back catastrophe years.
·Sep 14, 2:17 PMstreamnews
Top Technology Executives Recognized at the 2026 Carolina CIO ORBIE Awards
Leading CIOs honored for leadership, innovation, and business impact at the Carolina CIO ORBIE Awards on September 10, 2026, at The Westin Charlotte. CHARLOTTE, N.C., Sept. 14, 2026 (GLOBE NEWSWIRE) -- The 2026 Carolina CIO ORBIE Awards honored leading chief information officers (CIOs) from MetLife, Thermo Fisher Scientific, Armstrong Transport Group, Duke Energy, Beacon Mobility, Rodgers Builders, Hornets Sports & Entertainment, and North Carolina Rate Burreau for their exceptional leadership.
❖Sep 14, 10:19 AMnewsvia finnhub
Top Technology Executives Recognized at the 2026 Carolina CIO ORBIE Awards
Leading CIOs honored for leadership, innovation, and business impact at the Carolina CIO ORBIE Awards on September 10, 2026, at The Westin Charlotte. CHARLOTTE, N.C., Sept. 14, 2026 (GLOBE NEWSWIRE) -- The 2026 Carolina CIO ORBIE Awards honored leading chief information officers (CIOs) from MetLife, Thermo Fisher Scientific, Armstrong Transport Group, Duke Energy, Beacon Mobility, Rodgers Builders, Hornets Sports & Entertainment, and North Carolina Rate Burreau for their exceptional leadership.
❖Sep 13, 9:07 AMnewsvia finnhub
Higher Rates Are a Gift to These 3 Insurance Dividend Stocks
Insurance companies collect your premiums today and settle your claims years from now, and that gap is quietly becoming a profit engine as rates stay elevated. Three insurers are turning this float mechanic into dividend growth that outlasted a pandemic, an inflation shock, and back-to-back catastrophe years.
❖Sep 11, 9:35 AMnewsvia finnhub
9 Financials Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often
❖Sep 11, 4:40 AMnewsvia finnhub
MetLife (NYSE:MET) Sets Up for Breakout With Strong Technicals and High-Quality Consolidation
METLIFE stock shows a technical breakout: Technical Rating 8/10, Setup Quality 9/10, tight consolidation base, and defined entry levels.
❖Sep 9, 3:22 PMnewsvia finnhub
3 Reasons to Avoid MET and 1 Stock to Buy Instead
MetLife has had an impressive run over the past six months as its shares have beaten the S&P 500 by 21.8%. The stock now trades at $95.81, marking a 35.4% gain. This run-up might have investors contemplating their next move.
❖Sep 9, 9:25 AMnewsvia finnhub
Executive Waves Goodbye to More Than 6,000 Shares of Legendary Insurance Stock
Disposition was non-discretionary, executed to cover tax obligations from restricted stock unit vesting. McCallion retains 269,137 direct shares worth $25.4 million.
❖Sep 9, 7:57 AMnewsvia finnhub
MetLife, Inc. (MET) Presents at KBW Insurance Conference 2026 Transcript
MetLife, Inc. (MET) KBW Insurance Conference 2026 September 9, 2026 9:15 AM EDTCompany ParticipantsMichel Khalaf - CEO, President & DirectorJohn...
?Sep 8, 12:40 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is down 1.57% intraday, which is a moderate but not decisive move. As a large-cap insurer, MET is rate-sensitive, and the macro context shows the 5-year forward inflation rate (T5YIFR) printing 1.7σ above its 24-month trend — elevated inflation expectations can pressure insurers through liability duration and spread dynamics, providing a plausible macro tailwind for the downside move. However, several factors temper conviction: (1) no news headlines to anchor the move to a specific catalyst, making it harder to assess whether selling pressure is exhausted or ongoing; (2) at 1.57%, the move is meaningful but not extreme — it lacks the size signature of a high-conviction institutional flush; (3) 185 minutes remaining is ample time for either continuation or mean reversion, which is neutral rather than directionally supportive; (4) with no clear reversal signal either, there's no strong reason to fade. Net assessment: the macro backdrop leans modestly bearish for rate-sensitive financials like MET, the move has some real-flow credibility, and no reversal pattern is apparent. This is a borderline continuation setup — probability sits at the threshold where the system's bounded risk profile justifies taking the trade.
!Sep 8, 12:40 PMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
MET is down 1.57% intraday, which is a moderate but not decisive move. As a large-cap insurer, MET is rate-sensitive, and the macro context shows the 5-year forward inflation rate (T5YIFR) printing 1.7σ above its 24-month trend — elevated inflation expectations can pressure insurers through liability duration and spread dynamics, providing a plausible macro tailwind for the downside move. However, several factors temper conviction: (1) no news headlines to anchor the move to a specific catalyst, making it harder to assess whether selling pressure is exhausted or ongoing; (2) at 1.57%, the move is meaningful but not extreme — it lacks the size signature of a high-conviction institutional flush; (3) 185 minutes remaining is ample time for either continuation or mean reversion, which is neutral rather than directionally supportive; (4) with no clear reversal signal either, there's no strong reason to fade. Net assessment: the macro backdrop leans modestly bearish for rate-sensitive financials like MET, the move has some real-flow credibility, and no reversal pattern is apparent. This is a borderline continuation setup — probability sits at the threshold where the system's bounded risk profile justifies taking the trade.
❖Sep 7, 8:20 AMnewsvia finnhub
Is MetLife Outperforming the Nasdaq?
MetLife has outperformed the broader market over the past year, while analysts remain somewhat bullish on its future prospects.
❖Sep 4, 6:22 AMnewsvia finnhub
Jackson Financial: A Buyback Machine With An Attractive Valuation - Strong Buy
Jackson Financial (JXN) is misunderstood by the market, trading at highly attractive valuation metrics due to perceived earnings volatility.
❖Sep 3, 11:02 AMnewsvia finnhub
The Case for Holding MetLife Stock: What Investors Need to Know
MET's diversified portfolio, strong cash generation and global growth support premium gains, while investment income volatility remains a key risk.
❖Sep 3, 9:54 AMnewsvia finnhub
Chariot Re raises $700m to expand reinsurance platform
Chariot Re said the new capital will help it scale its life and annuity reinsurance business and pursue a growing pipeline of diversified opportunities.
?Sep 3, 9:40 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up 2.22% intraday with no attributable headline, suggesting institutional flow or sector rotation rather than a news-driven spike. With 365 minutes remaining (essentially a full trading day still ahead — likely this is a pre-market or early morning read), there is ample time for the move to extend. The macro context is notable: 5-year forward inflation expectations (T5YIFR) are running 1.7σ above trend at 2.33, which is meaningful for rate-sensitive sectors. MET as a large-cap insurer/financial has a complex relationship with rates — elevated inflation expectations can support insurance pricing power and investment income on float, which is net constructive for MET's business model. This inflation-rate backdrop provides a plausible fundamental tailwind supporting the move. No reversal signals are evident, no fade pattern is described, and the absence of news does not negate the move. The 2.22% magnitude reflects real conviction from size players. Probability is modest (not high-conviction) given no specific catalyst confirmation and the macro factor cutting somewhat against broader rate-sensitive names if rising rates also signal tightening financial conditions, but the balance of evidence favors continuation over fade.
!Sep 3, 9:40 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MET is up 2.22% intraday with no attributable headline, suggesting institutional flow or sector rotation rather than a news-driven spike. With 365 minutes remaining (essentially a full trading day still ahead — likely this is a pre-market or early morning read), there is ample time for the move to extend. The macro context is notable: 5-year forward inflation expectations (T5YIFR) are running 1.7σ above trend at 2.33, which is meaningful for rate-sensitive sectors. MET as a large-cap insurer/financial has a complex relationship with rates — elevated inflation expectations can support insurance pricing power and investment income on float, which is net constructive for MET's business model. This inflation-rate backdrop provides a plausible fundamental tailwind supporting the move. No reversal signals are evident, no fade pattern is described, and the absence of news does not negate the move. The 2.22% magnitude reflects real conviction from size players. Probability is modest (not high-conviction) given no specific catalyst confirmation and the macro factor cutting somewhat against broader rate-sensitive names if rising rates also signal tightening financial conditions, but the balance of evidence favors continuation over fade.
❖Sep 2, 3:36 PMnewsvia finnhub
1 S&P 500 Stock with Impressive Fundamentals and 2 We Avoid
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant challenges, whether it’s stagnating growth, heavy debt, or disruptive new competitors.
?Sep 2, 2:45 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up 2.63% intraday with no attributable headline, suggesting institutional flow or sector rotation rather than news-driven spike — both can sustain. The macro context shows 5Y5Y inflation forward at 1.7σ above trend, which is modestly supportive for insurers like MET: higher long-end rate expectations benefit life insurers' investment income and reserve valuations, creating a plausible fundamental tailwind. However, several factors temper conviction: (1) only 60 minutes remain until forced close, limiting runway for further gains toward the +3% target from current levels (would require roughly another +0.4% from here — achievable but tight); (2) no confirming news or catalyst makes the move harder to assess for durability; (3) at 2.63% already, some mean-reversion pressure is natural as late-session profit-taking often emerges in the final hour. The risk/reward still slightly favors continuation given the bounded downside (-1.5% stop) and the small incremental move needed to hit target, but this is a low-conviction setup. Probability set just above the 0.5 threshold reflecting ordinary momentum with no strong fade catalyst.
!Sep 2, 2:45 PMsignalseverity 0.03
Agent 7 — Day Trader — day_trade_skipped
MET is up 2.63% intraday with no attributable headline, suggesting institutional flow or sector rotation rather than news-driven spike — both can sustain. The macro context shows 5Y5Y inflation forward at 1.7σ above trend, which is modestly supportive for insurers like MET: higher long-end rate expectations benefit life insurers' investment income and reserve valuations, creating a plausible fundamental tailwind. However, several factors temper conviction: (1) only 60 minutes remain until forced close, limiting runway for further gains toward the +3% target from current levels (would require roughly another +0.4% from here — achievable but tight); (2) no confirming news or catalyst makes the move harder to assess for durability; (3) at 2.63% already, some mean-reversion pressure is natural as late-session profit-taking often emerges in the final hour. The risk/reward still slightly favors continuation given the bounded downside (-1.5% stop) and the small incremental move needed to hit target, but this is a low-conviction setup. Probability set just above the 0.5 threshold reflecting ordinary momentum with no strong fade catalyst.
?Sep 2, 10:40 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up 2.62% intraday with no attributable headline, suggesting institutional flow rather than a news-driven spike that might fade. MetLife is a large insurer and rate-sensitive name — the macro backdrop shows 5Y5Y forward inflation (T5YIFR) at 2.33, running 1.7σ above its 24-month trend, which implies elevated long-end rate expectations. That environment is broadly constructive for life insurers like MET, as higher rates widen net investment income spreads and boost reserve discount rates. With 305 minutes remaining (just over 5 hours), there is ample time for continuation into the close. No reversal signals are noted — no headline catalyst to fade against, no mention of thin volume. The primary drag on conviction is the absence of any confirming news flow and the fact that a 2.62% move has already captured meaningful alpha, raising the risk of afternoon profit-taking. On balance, the rate-tailwind sector context and the meaningful size of the initial move suggest real directional conviction from institutional participants, supporting a modest continuation bias.
!Sep 2, 10:40 AMsignalseverity 0.03
Agent 7 — Day Trader — day_trade_skipped
MET is up 2.62% intraday with no attributable headline, suggesting institutional flow rather than a news-driven spike that might fade. MetLife is a large insurer and rate-sensitive name — the macro backdrop shows 5Y5Y forward inflation (T5YIFR) at 2.33, running 1.7σ above its 24-month trend, which implies elevated long-end rate expectations. That environment is broadly constructive for life insurers like MET, as higher rates widen net investment income spreads and boost reserve discount rates. With 305 minutes remaining (just over 5 hours), there is ample time for continuation into the close. No reversal signals are noted — no headline catalyst to fade against, no mention of thin volume. The primary drag on conviction is the absence of any confirming news flow and the fact that a 2.62% move has already captured meaningful alpha, raising the risk of afternoon profit-taking. On balance, the rate-tailwind sector context and the meaningful size of the initial move suggest real directional conviction from institutional participants, supporting a modest continuation bias.
❖Sep 1, 11:05 AMnewsvia finnhub
MetLife 2025 Sustainability Report: Strengthening Our Communities
NORTHAMPTON, MA / ACCESS Newswire / September 1, 2026 / and Foundation's giving and volunteerism help strengthen the resilience of the communities we serve. This work complements our environmental stewardship efforts, forming a cohesive approach to helping communities thrive in multiple ways.
▣Aug 31, 8:00 PMjournalrotation
Agent 17 — 52-Week High Momentum closed long 51 @ $95.17 (-$59.16)
52-Week High monthly rebalance. Position dropped from top 20.
❖Aug 30, 7:01 AMnewsvia finnhub
US Debt is Nearing $40.1 Trillion: Top Three Stock Sectors Set to Benefit
The US debt is now nearing the important milestone of $40.1 trillion a few days after it crossed the $40T milestone. Top stock sectors set to benefit
❖Aug 29, 7:42 AMnewsvia finnhub
Why The Fed Might Raise Rates Despite August Job Declines
❖Aug 28, 6:04 PMnewsvia finnhub
Dividend Champion, Contender, And Challenger Highlights: Week August 30
Dividend activity recap for Champions, Contenders & Challengers: dividend changes plus upcoming ex-dividend and pay dates. See more here.
?Aug 24, 1:46 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up 1.60% today, a modest but real move suggesting some institutional flow. The macro context shows 5-year forward inflation expectations (T5YIFR) running 1.8σ above trend — elevated inflation expectations are generally a mixed signal for life insurers like MET. On one hand, higher rates/inflation expectations can compress liability values and support insurer investment income; on the other hand, if this is read as a risk-off or tightening signal, it could fade equity gains. No news headlines are present, so we cannot attribute the move to a catalyst, but that does not disqualify continuation. The move at 1.60% is below the 2% threshold where momentum becomes more self-sustaining. With 120 minutes remaining there is adequate time for the trade to work toward the +3% target, and stops are bounded at -1.5%. No evidence of reversal pattern or fade is present. In the absence of a clear reason to expect fade, and with sufficient time remaining, a slight lean toward continuation is warranted, though conviction is limited given the mild macro headwind from elevated inflation expectations for rate-sensitive financials and the absence of a clear catalyst.
!Aug 24, 1:46 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MET is up 1.60% today, a modest but real move suggesting some institutional flow. The macro context shows 5-year forward inflation expectations (T5YIFR) running 1.8σ above trend — elevated inflation expectations are generally a mixed signal for life insurers like MET. On one hand, higher rates/inflation expectations can compress liability values and support insurer investment income; on the other hand, if this is read as a risk-off or tightening signal, it could fade equity gains. No news headlines are present, so we cannot attribute the move to a catalyst, but that does not disqualify continuation. The move at 1.60% is below the 2% threshold where momentum becomes more self-sustaining. With 120 minutes remaining there is adequate time for the trade to work toward the +3% target, and stops are bounded at -1.5%. No evidence of reversal pattern or fade is present. In the absence of a clear reason to expect fade, and with sufficient time remaining, a slight lean toward continuation is warranted, though conviction is limited given the mild macro headwind from elevated inflation expectations for rate-sensitive financials and the absence of a clear catalyst.
❖Aug 24, 7:57 AMnewsvia finnhub
Morgan Stanley Maintains Overweight on MetLife, Raises Price Target to $111
Morgan Stanley analyst Nigel Dally maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $103 to $111.
❖Aug 9, 4:30 AMnewsvia finnhub
Aflac: Reliable Dividend Compounder, Premium Justified, But Meaningful Upside Unlikely
❖Aug 8, 2:03 PMnewsvia finnhub
MetLife Q2 Earnings Call Highlights
MetLife (NYSE:MET) reported second-quarter 2026 adjusted earnings of approximately $1.6 billion, or $2.43 per share, up 15% from a year earlier. Adjusted earnings per share increased 20%, while adjusted return on equity reached 17%, the top end of the company’s 15% to 17% annual target range. Presi
?Aug 7, 1:41 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is down ~2.46% today, which is meaningful flow, but there are countervailing factors that push against continuation. The $3B share repurchase authorization announced mid-session is a significant bullish catalyst — buyback authorizations of this size typically attract dip buyers and signal management confidence, which could absorb selling pressure and support a reversal or stabilization into the close. The Aflac earnings miss is a mild negative read-across for the insurance sector, but MET-specific news is net positive. Macro context shows 5Y inflation expectations 1.5σ below trend, which is generally supportive of financial/insurance names (lower discount rates, favorable liability duration dynamics). With 124 minutes remaining there is ample time for price to move, but the buyback announcement is a concrete near-term support mechanism. The setup does not have clear continuation pressure — the down move appears to lack a strong fundamental driver (no MET-specific negative catalyst), and the repurchase news actively works against it. This edges below the 0.5 threshold, favoring a fade rather than continuation of the decline.
!Aug 7, 1:41 PMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
MET is down ~2.46% today, which is meaningful flow, but there are countervailing factors that push against continuation. The $3B share repurchase authorization announced mid-session is a significant bullish catalyst — buyback authorizations of this size typically attract dip buyers and signal management confidence, which could absorb selling pressure and support a reversal or stabilization into the close. The Aflac earnings miss is a mild negative read-across for the insurance sector, but MET-specific news is net positive. Macro context shows 5Y inflation expectations 1.5σ below trend, which is generally supportive of financial/insurance names (lower discount rates, favorable liability duration dynamics). With 124 minutes remaining there is ample time for price to move, but the buyback announcement is a concrete near-term support mechanism. The setup does not have clear continuation pressure — the down move appears to lack a strong fundamental driver (no MET-specific negative catalyst), and the repurchase news actively works against it. This edges below the 0.5 threshold, favoring a fade rather than continuation of the decline.
❖Aug 7, 12:48 PMnewsvia finnhub
AIG Beats Q2 Earnings Estimates on Robust Underwriting Income
American International beats Q2 earnings estimates as stronger underwriting and lower catastrophe losses offset weaker investment income.
❖Aug 7, 10:48 AMnewsvia finnhub
Aflac Misses Q2 EPS Estimates Despite Solid US Sales Growth
Aflac's Q2 adjusted EPS misses estimates as lower investment income and FX weigh, but U.S. sales, policy persistency and capital returns offer support.
?Aug 7, 9:56 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is down 1.82% intraday, which is a meaningful move but not extreme for a large-cap insurer. No news headlines are available to explain the move, which limits conviction in either direction. The macro context shows 5Y inflation expectations (T5YIE) printing 1.5σ below trend — a disinflationary signal that is marginally negative for insurance/financials since lower inflation expectations can compress investment income assumptions and flatten yield curves, offering modest continuation support for the downside. However, with 350 minutes still remaining (nearly a full session left), there is ample time for both continuation and mean reversion. The move is not large enough to signal a decisive breakdown, and without a news catalyst or clear sector-wide sell program visible, the setup is borderline. The asymmetric payoff structure (tight -1.5% stop vs. +3% target) tips the call to take the trade on the down side at the minimum threshold, but no strong incremental conviction beyond a coin-flip plus slight macro tailwind justifies going higher.
!Aug 7, 9:56 AMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
MET is down 1.82% intraday, which is a meaningful move but not extreme for a large-cap insurer. No news headlines are available to explain the move, which limits conviction in either direction. The macro context shows 5Y inflation expectations (T5YIE) printing 1.5σ below trend — a disinflationary signal that is marginally negative for insurance/financials since lower inflation expectations can compress investment income assumptions and flatten yield curves, offering modest continuation support for the downside. However, with 350 minutes still remaining (nearly a full session left), there is ample time for both continuation and mean reversion. The move is not large enough to signal a decisive breakdown, and without a news catalyst or clear sector-wide sell program visible, the setup is borderline. The asymmetric payoff structure (tight -1.5% stop vs. +3% target) tips the call to take the trade on the down side at the minimum threshold, but no strong incremental conviction beyond a coin-flip plus slight macro tailwind justifies going higher.
❖Aug 7, 8:16 AMnewsvia finnhub
MetLife Stock: Analyst Estimates & Ratings
MetLife has outperformed the broader market over the past year, and analysts are cautiously optimistic about the stock’s prospects.
❖Aug 7, 8:14 AMnewsvia finnhub
MetLife (MET) Approved A $3 Billion Share Repurchase Authorization
MetLife (NYSE: MET) announced that its board of directors has approved a new US$3b share repurchase authorization. The buyback authorization adds a fresh layer to MetLife's capital return plans and offers the board flexibility over future share repurchases. The decision signals the insurer's confidence in its balance sheet and long term capital allocation approach. MetLife is far from the only large insurer using buybacks and dividends to return capital to investors. It is therefore worth...
✓Aug 6, 12:50 PMdecisionacted
Agent 7 — Day Trader — decide: buy
MET is up 3.72% on Q2 2026 earnings day, with the earnings call transcript and presentation dropping mid-session. This is a clear earnings-driven gap/run with fundamental catalyst. Barclays raised its price target to $97 (now trading above that at $99.84), suggesting the market is re-rating higher than the analyst target — which typically indicates strong buy-side demand absorbing the news. With 175 minutes remaining there is ample time for continuation. The macro context (T5YIE at 1.9σ below trend, indicating lower inflation expectations) is mildly supportive for insurers/financials as it implies a benign rate environment. No reversal signals are noted — the move appears directional rather than a fade off highs. The main drag is that MET has already exceeded the Barclays PT, which could invite some profit-taking or resistance, and the sustainability report/pet insurance award headlines are minor. Overall, earnings momentum with time remaining and no adverse macro headwinds supports modest continuation probability.
❖Aug 6, 12:29 PMnewsvia finnhub
MetLife Tops Q2 Earnings Estimates on Strong Investment Income
MET tops Q2 EPS estimates as higher investment income, favorable underwriting and business volume growth lift earnings despite higher expenses.
❖Aug 6, 10:44 AMnewsvia finnhub
MetLife's Q2 Earnings Beat Reaffirms The Buy Case As Organic Growth Stands Out
MetLife stock remains a Buy due to strong fundamentals, organic growth, and a resilient dividend. Click here to see MET's valuation upside to 2026 & key risks.
❖Aug 6, 8:35 AMnewsvia finnhub
MetLife 2025 Sustainability Report: Talent and Skills Development
MetLife NORTHAMPTON, MA / ACCESS Newswire / August 6, 2026 / MetLife's foundation of learning and professional development enhances our workforce's ability to move with speed and discipline to deliver results in a changing world. Our approach emphasizes ...
❖Aug 6, 8:30 AMnewsvia finnhub
MetLife, Inc. Q2 2026 Earnings Call Summary
Moby summary of MetLife, Inc.'s Q2 2026 earnings call
❖Aug 6, 8:14 AMnewsvia finnhub
MetLife, Inc. (MET) Q2 2026 Earnings Call Transcript
MetLife, Inc. (MET) Q2 2026 Earnings Call August 6, 2026 9:00 AM EDTCompany ParticipantsJohn Hall - Senior VP, Head of Investor Relations & Executive VP...
❖Aug 6, 8:01 AMnewsvia finnhub
MetLife, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-06. The following slide deck was published by MetLife, Inc.
❖Aug 6, 8:00 AMnewsvia finnhub
MetLife Pet Insurance Winner Of 2026 Pet Innovation Award For “Pet Insurance of the Year”
Annual Awards Program Recognizes Companies, Services And Products Within The Rapidly Expanding Pet Industry That Exemplify Excellence & InnovationLOS ANGELES, Aug. 06, 2026 (GLOBE NEWSWIRE) -- The 2026 Pet Innovation Awards today announced that MetLife Pet Insurance is the recipient of the “Pet Insurance of the Year” award. The Pet Innovation Awards is an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Pet care industr
❖Aug 6, 6:36 AMnewsvia finnhub
Barclays Maintains Overweight on MetLife, Raises Price Target to $97
Barclays analyst Alex Scott maintains MetLife (NYSE:MET) with a Overweight and raises the price target from $94 to $97.
❖Aug 5, 9:00 PMnewsvia finnhub
Compared to Estimates, MetLife (MET) Q2 Earnings: A Look at Key Metrics
The headline numbers for MetLife (MET) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
▢Aug 5, 8:00 PMjournal
Agent 7 — Day Trader opened long 29 @ $99.85
▣Aug 5, 8:00 PMjournaltime_stop
Agent 7 — Day Trader closed long 29 @ $99.76 (-$2.46)
EOD forced close — day trader never carries overnight
❖Aug 5, 5:16 PMnewsvia finnhub
MetLife (NYSE:MET) Misses Q2 CY2026 Revenue Estimates
Global insurance giant MetLife (NYSE:MET) fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 6.9% year on year to $19.15 billion. Its non-GAAP profit of $2.43 per share was 6.2% above analysts’ consensus estimates.
❖Aug 5, 4:30 PMnewsvia finnhub
MetLife Announces New $3 Billion Share Repurchase Authorization
NEW YORK, August 05, 2026--MetLife, Inc. (NYSE: MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the approximately $400 million remaining under the company’s prior authorization announced in April 2025.
❖Aug 5, 4:20 PMnewsvia finnhub
MetLife CFO John McCallion Provides Second Quarter 2026 Financial Update Video
NEW YORK, August 05, 2026--MetLife, Inc. (NYSE: MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided a second quarter 2026 financial update video.
❖Aug 5, 4:15 PMnewsvia finnhub
MetLife Announces 2Q 2026 Results
NEW YORK, August 05, 2026--MetLife, Inc. (NYSE: MET) today announced its second quarter 2026 results.
❖Aug 4, 7:00 PMnewsvia finnhub
Corebridge Financial (CRBG) Tops Q2 Earnings Estimates
Corebridge (CRBG) delivered earnings and revenue surprises of +3.70% and -4.67%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
❖Aug 4, 9:30 AMnewsvia finnhub
ALL, MET or RDN: Which Insurer is Best Positioned for a Q2 Beat?
Commercial pricing, investment income and underwriting trends are in focus as Allstate, MetLife and Radian Group prepare to report Q2 earnings.
❖Aug 4, 12:45 AMnewsvia finnhub
1 Large-Cap Stock to Target This Week and 2 We Brush Off
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task.
❖Aug 3, 1:52 PMnewsvia finnhub
Octave Specialty Group to Report Q2 Earnings: What to Expect
Octave Specialty heads into Q2 results with revenues projected to jump 47.4%. The bottom line is likely to improve y/y, though the model does not signal a beat.
❖Aug 3, 12:22 PMnewsvia finnhub
Can Better Japan Profitability Support Aflac's Q2 Earnings Beat?
AFL's improved Japan benefit-to-premium ratio may help offset premium and investment income pressure ahead of its Aug. 6 Q2 earnings report.
❖Aug 3, 12:05 PMnewsvia finnhub
Can MetLife Deliver a Q2 Earnings Beat on Group Benefits Strength?
MET heads into Q2 results with rising earnings estimates and expected strength in Group Benefits and Retirement & Income Solutions. Will it deliver a beat?
❖Aug 3, 8:15 AMnewsvia finnhub
MetLife Investment Management Closes $1.2 Billion Private Equity Partners Fund III Through Managed Transaction
WHIPPANY, N.J., August 03, 2026--MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE: MET), today announced the closing of approximately $1.2 billion in commitments to MetLife Investment Private Equity Partners Fund III (MIPEP III), the third fund in MIM's private equity investment platform for institutional investors.
▢Aug 2, 8:00 PMjournal
Agent 17 — 52-Week High Momentum opened long 51 @ $96.33
❖Aug 1, 7:30 AMnewsvia finnhub
SpaceX's First Earnings Post IPO
Wall Street Week Ahead: key earnings (SpaceX, AMD), IPOs, dividends & macro data (PMIs, jobs). Read here for more details.
❖Jul 31, 5:18 PMnewsvia finnhub
Dividend Champion, Contender, And Challenger Highlights: Week August 2
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read now.
❖Jul 31, 9:15 AMnewsvia finnhub
Unlocking Q2 Potential of MetLife (MET): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of MetLife (MET) for the quarter ended June 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
❖Jul 29, 10:00 AMnewsvia finnhub
Fidelity National Financial (FNF) Reports Next Week: Wall Street Expects Earnings Growth
Fidelity National Financial (FNF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
?Jul 27, 6:04 PMdecisionconsidered
Agent 20 — SIR Price/Volume — buy
[not executed — reserve_floor_or_cash] [cluster_break_up] From 2026-07-09 through 2026-07-23, MET's PV path carved a tight cluster between roughly $91.15 and $94.00 on consistently subdued volume (ranging 2.0M–4.1M, near or below the 3.4M ADV), with no single session breaking decisively higher — a textbook low-volume consolidation node in SIR 2-D space. The setup began to activate on 2026-07-24, when the close surged to $94.83 on 4.5M volume (a modest up-day pop above the cluster ceiling), and today's bar (2026-07-27, close $95.19, volume 7.0M, z-score +5.55) completes the breakout: price has cleared the top of the 2-week cluster on volume more than double the trailing 20-day mean and more than 50% above the next-highest session in the window. In SIR's 2-D framework, the dot has moved decisively up-and-right — out of the congestion zone — which is the signature cluster_break_up signal of fresh demand absorbing the available float. Risks: The primary invalidation would be a failure bar — a next-session close back below ~$93.50 (the cluster top) on sustained high volume, which would re-enter the congestion zone and expose today's spike as a single-bar exhaustion/false-breakout rather than confirmed demand. Separately, macro context shows the 5-year inflation breakeven (T5YIE) printing 1.6σ below trend on 2026-07-24, which could signal a risk-off or deflation scare that disproportionately weighs on Financials sector earnings expectations and caps upside follow-through.
❖Jul 27, 9:10 AMnewsvia finnhub
MetLife 2025 Sustainability Report: Expanding Access to Financial Services
NORTHAMPTON, MA / ACCESS Newswire / July 27, 2026 /MetLife Through digital distribution and local partnerships, we develop solutions to meet customers where they are, expanding access to resources, care and financial support across communities.1 This ...
❖Jul 25, 6:25 PMnewsvia finnhub
Tracking David Einhorn's Greenlight Capital Portfolio - Q1 2026 Update
Greenlight Capital's 13F portfolio rose from $2.85B to $3.19B in Q1 2026, outperforming the S&P 500 with a 6.5% return vs. -4.4%. Read more on the portfolio here.
❖Jul 25, 11:12 AMnewsvia finnhub
MetLife (MET) Stock Looks Below Fair Value While Earnings Sit Above Fair Value
MetLife stock has nearly doubled investors' money over the past five years, yet there is a clear split in what the current price implies, with the Excess Returns intrinsic value estimate pointing to a sizeable discount while earnings-based multiples lean in the opposite direction. Over the past five years, MetLife has delivered a 91.4% total return, which puts more pressure on today's valuation to be supported by future cash flows rather than past price gains. The valuation can be helped if...
?Jul 24, 8:06 PMdecisionconsidered
Agent 20 — SIR Price/Volume — buy
[not executed — reserve_floor_or_cash] [cluster_break_up] From 2026-07-09 through 2026-07-23, MET formed a tight price cluster in the $91.15–$94.00 range on notably subdued volume (daily readings of 2.0M–4.1M, well below the 20-day ADV of 3.4M on most sessions), a classic SIR consolidation coil. Today's bar on 2026-07-24 — close $94.83, volume 6.9M (z-score +4.45 vs. the trailing 20-day mean) — breaks decisively above that cluster on more than double the recent median volume, exactly the "fresh demand absorbing the float" signature SIR identifies as a cluster_break_up. Importantly, this is not an isolated event: the broader 20-day path already showed a constructive up-and-right drift from the $85.95 close on 2026-06-26 to the pre-cluster highs near $94, indicating prior accumulation before today's volume confirmation. Risks: The macro backdrop is a headwind: the T10Y2Y spread of 0.34 (2.0σ below trend as of 2026-07-23) signals a flattening curve that is historically negative for Financials/insurers like MET, and any further flattening or re-inversion could compress net investment income expectations and reverse the breakout. A close back below $92.50 (the lower bound of the July consolidation cluster) on elevated volume would constitute a failed breakout and invalidate this read entirely.
?Jul 13, 1:45 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up 1.50% today, a moderate but meaningful move suggesting real buying interest. The move is below the 2-5% threshold that would signal strong conviction, so it carries less inherent momentum signal. The macro context is a mild headwind: the T10Y2Y at 0.35 is 2.1σ below its 24-month trend, indicating a flatter/slightly inverted curve environment, which is typically negative for financials/insurers like MET. However, the spread is still positive (not inverted), limiting the severity of this drag. No news catalysts are present either way. With 120 minutes remaining, there is adequate time for continuation. The flat curve context provides a modest reason to temper enthusiasm, but not enough to expect a clear fade — the absence of a reversal pattern and reasonable time remaining keep continuation as the base case at a slim margin above neutral.
!Jul 13, 1:45 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MET is up 1.50% today, a moderate but meaningful move suggesting real buying interest. The move is below the 2-5% threshold that would signal strong conviction, so it carries less inherent momentum signal. The macro context is a mild headwind: the T10Y2Y at 0.35 is 2.1σ below its 24-month trend, indicating a flatter/slightly inverted curve environment, which is typically negative for financials/insurers like MET. However, the spread is still positive (not inverted), limiting the severity of this drag. No news catalysts are present either way. With 120 minutes remaining, there is adequate time for continuation. The flat curve context provides a modest reason to temper enthusiasm, but not enough to expect a clear fade — the absence of a reversal pattern and reasonable time remaining keep continuation as the base case at a slim margin above neutral.
?Jul 8, 1:36 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is down 1.77% today, a moderate but not emphatic move. The macro context is a key headwind to continuation: the T10Y2Y spread printed at 0.36, noted as 2.0σ below its 24-month trend, indicating a flattening/near-inversion dynamic. This is generally negative for financials/insurers like MET, which could support the downside move. However, the spread reading is from yesterday (2026-07-07), so some of that signal may already be priced in — MET may have already absorbed the yield-curve pressure. With 130 minutes remaining, there is ample time for continuation OR for a mean-reversion bounce, as institutional players often fade mid-session moves in large-cap financials absent fresh catalysts. No fresh headlines provide directional conviction, and the move at -1.77% is meaningful but sits below the 2-5% threshold that would signal strong institutional conviction. The yield curve context leans slightly bearish for MET, but the absence of news and moderate move size suggest fade risk is real. Probability sits just below the 0.5 trigger threshold — this is a borderline pass.
!Jul 8, 1:36 PMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
MET is down 1.77% today, a moderate but not emphatic move. The macro context is a key headwind to continuation: the T10Y2Y spread printed at 0.36, noted as 2.0σ below its 24-month trend, indicating a flattening/near-inversion dynamic. This is generally negative for financials/insurers like MET, which could support the downside move. However, the spread reading is from yesterday (2026-07-07), so some of that signal may already be priced in — MET may have already absorbed the yield-curve pressure. With 130 minutes remaining, there is ample time for continuation OR for a mean-reversion bounce, as institutional players often fade mid-session moves in large-cap financials absent fresh catalysts. No fresh headlines provide directional conviction, and the move at -1.77% is meaningful but sits below the 2-5% threshold that would signal strong institutional conviction. The yield curve context leans slightly bearish for MET, but the absence of news and moderate move size suggest fade risk is real. Probability sits just below the 0.5 trigger threshold — this is a borderline pass.
?Jul 8, 11:25 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is down 1.83% with 260 minutes remaining — a meaningful but not outsized move for a large-cap insurer. The macro backdrop is a mild headwind: T10Y2Y at 0.36 (2σ below trend) signals a flatter/more compressed yield curve, which is broadly negative for financial sector earnings power including life insurers like MET that benefit from spread income. However, MET is more of an insurance/asset manager than a pure bank, so the yield curve sensitivity is moderate rather than acute. No headlines are present to explain the move, which means it could be driven by sector rotation, macro repricing, or thin technical flows — any of which can sustain or fade without warning. With 260 minutes remaining there is ample time for continuation, but the move is below the 2-5% threshold where momentum alone becomes compelling evidence of institutional conviction. The macro context provides a mild directional tailwind to the downside but not strong enough to push probability above 0.55. Baseline momentum continuation with no countervailing catalyst to fade it, combined with a yield-curve environment that modestly favors further weakness in financials, yields a marginal continuation call.
!Jul 8, 11:25 AMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
MET is down 1.83% with 260 minutes remaining — a meaningful but not outsized move for a large-cap insurer. The macro backdrop is a mild headwind: T10Y2Y at 0.36 (2σ below trend) signals a flatter/more compressed yield curve, which is broadly negative for financial sector earnings power including life insurers like MET that benefit from spread income. However, MET is more of an insurance/asset manager than a pure bank, so the yield curve sensitivity is moderate rather than acute. No headlines are present to explain the move, which means it could be driven by sector rotation, macro repricing, or thin technical flows — any of which can sustain or fade without warning. With 260 minutes remaining there is ample time for continuation, but the move is below the 2-5% threshold where momentum alone becomes compelling evidence of institutional conviction. The macro context provides a mild directional tailwind to the downside but not strong enough to push probability above 0.55. Baseline momentum continuation with no countervailing catalyst to fade it, combined with a yield-curve environment that modestly favors further weakness in financials, yields a marginal continuation call.
?Jul 2, 3:11 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET has moved +2.16% today with 35 minutes remaining until the forced close. The move is meaningful and suggests real institutional flow, but several factors weigh against continuation. First, time is the primary constraint — with only 35 minutes left, the window for additional upside is narrow, and late-session profit-taking or mean reversion is common after a move of this magnitude. Second, the macro context is modestly unfavorable for MET: 10Y inflation breakevens (T10YIE) are printing 1.6σ below trend, which signals lower inflation expectations. For an insurer like MetLife, lower long-duration rates and suppressed inflation expectations can compress investment income expectations, creating a headwind to further upside. Third, there are no catalysts (no headlines) to sustain buying conviction into the close. The move appears technically driven rather than news-driven, raising the probability of fade as fast money takes profit. The combination of limited time, macro headwind for the insurance sector, and no fresh catalyst tips this just below the 0.5 threshold. Not taking the position.
!Jul 2, 3:11 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MET has moved +2.16% today with 35 minutes remaining until the forced close. The move is meaningful and suggests real institutional flow, but several factors weigh against continuation. First, time is the primary constraint — with only 35 minutes left, the window for additional upside is narrow, and late-session profit-taking or mean reversion is common after a move of this magnitude. Second, the macro context is modestly unfavorable for MET: 10Y inflation breakevens (T10YIE) are printing 1.6σ below trend, which signals lower inflation expectations. For an insurer like MetLife, lower long-duration rates and suppressed inflation expectations can compress investment income expectations, creating a headwind to further upside. Third, there are no catalysts (no headlines) to sustain buying conviction into the close. The move appears technically driven rather than news-driven, raising the probability of fade as fast money takes profit. The combination of limited time, macro headwind for the insurance sector, and no fresh catalyst tips this just below the 0.5 threshold. Not taking the position.
✓Jul 2, 12:19 PMdecisionacted
options_momentum — decide: buy
CALL on MET — 5-day return 5.20% with close above 20-day MA ($86.23). IV 27.8%. Sized 1 contract(s) at $3.31 premium.
?Jul 1, 10:01 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up 1.60% intraday with no specific news catalyst identified. The move is meaningful but not outsized for an insurance/financial name. Macro context shows 5-year inflation expectations (T5YIE) running 1.6σ below trend, which is modestly supportive for financials like MET insofar as lower inflation expectations reduce liability discount rate pressure, though this is a soft tailwind at best. With 345 minutes remaining (essentially a full trading day still ahead), there is ample time for continuation, but also ample time for mean reversion. No reversal signals are evident from the data provided, and no negative headlines exist to drive a fade. The absence of a clear catalyst means this is ordinary momentum — the move likely reflects sector rotation or institutional positioning. With tight stops and a fixed profit target, the borderline read resolves modestly in favor of continuation, but conviction is low.
!Jul 1, 10:01 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MET is up 1.60% intraday with no specific news catalyst identified. The move is meaningful but not outsized for an insurance/financial name. Macro context shows 5-year inflation expectations (T5YIE) running 1.6σ below trend, which is modestly supportive for financials like MET insofar as lower inflation expectations reduce liability discount rate pressure, though this is a soft tailwind at best. With 345 minutes remaining (essentially a full trading day still ahead), there is ample time for continuation, but also ample time for mean reversion. No reversal signals are evident from the data provided, and no negative headlines exist to drive a fade. The absence of a clear catalyst means this is ordinary momentum — the move likely reflects sector rotation or institutional positioning. With tight stops and a fixed profit target, the borderline read resolves modestly in favor of continuation, but conviction is low.
?Jun 24, 1:01 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is down 3.08% intraday with no attributable headline, suggesting institutional flow or sector rotation rather than a news-driven spike that might quickly reverse. The macro context shows T10YIE at 2.0σ below its 24-month trend, meaning inflation expectations are compressed and long-duration sensitive sectors face pressure — MET as a large-cap insurer with significant investment portfolio sensitivity to rates and spreads is a plausible candidate for continued selling in this environment (lower yields compress investment income expectations). With 165 minutes remaining, there is ample time for the move to extend toward the close. No reversal signal is visible — no news catalyst suggesting the selling was an overreaction, no fade pattern described. The absence of headlines cuts both ways but does not argue for reversal. The move magnitude (just over 3%) is meaningful but not so extreme as to suggest exhaustion or a snapback squeeze is imminent. Overall, the path of least resistance into the close is mildly lower, but conviction is modest given no confirming headline and the macro tailwind (lower yields) is ambiguous for insurers — it pressures investment income but also reduces discount rates on liabilities. Probability set slightly above 0.5 to take advantage of the system's asymmetric stop/target structure.
!Jun 24, 1:01 PMsignalseverity -0.03
Agent 7 — Day Trader — day_trade_skipped
MET is down 3.08% intraday with no attributable headline, suggesting institutional flow or sector rotation rather than a news-driven spike that might quickly reverse. The macro context shows T10YIE at 2.0σ below its 24-month trend, meaning inflation expectations are compressed and long-duration sensitive sectors face pressure — MET as a large-cap insurer with significant investment portfolio sensitivity to rates and spreads is a plausible candidate for continued selling in this environment (lower yields compress investment income expectations). With 165 minutes remaining, there is ample time for the move to extend toward the close. No reversal signal is visible — no news catalyst suggesting the selling was an overreaction, no fade pattern described. The absence of headlines cuts both ways but does not argue for reversal. The move magnitude (just over 3%) is meaningful but not so extreme as to suggest exhaustion or a snapback squeeze is imminent. Overall, the path of least resistance into the close is mildly lower, but conviction is modest given no confirming headline and the macro tailwind (lower yields) is ambiguous for insurers — it pressures investment income but also reduces discount rates on liabilities. Probability set slightly above 0.5 to take advantage of the system's asymmetric stop/target structure.
?Jun 24, 9:45 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is down 2.20% today with no headline catalyst identified, suggesting this is likely flow-driven or sector-rotation pressure. The macro context shows T10YIE at 2.21, running 2.0σ below its 24-month trend — meaningfully lower inflation expectations. For an insurance/financial company like MET, lower long-term inflation expectations can compress investment income outlooks and weigh on the stock, providing a plausible macro tailwind for the downside move to continue. However, several factors limit conviction: (1) with 360 minutes remaining the session is effectively just beginning, meaning there is ample time for reversal if the move was driven by an early-session imbalance that gets absorbed; (2) a 2.20% move in MET without a news catalyst could reflect a gap from overnight or early-morning institutional rebalancing that may already be largely complete; (3) no volume data or reversal pattern information is available to confirm sustained selling pressure. The macro backdrop is modestly supportive of continued weakness for a long-duration-sensitive financial name, but the absence of a clear catalyst and the long time horizon reduce certainty. Assigning a modest continuation probability slightly above threshold — the bounded risk profile justifies taking the trade on this lean.
!Jun 24, 9:45 AMsignalseverity -0.02
Agent 7 — Day Trader — day_trade_skipped
MET is down 2.20% today with no headline catalyst identified, suggesting this is likely flow-driven or sector-rotation pressure. The macro context shows T10YIE at 2.21, running 2.0σ below its 24-month trend — meaningfully lower inflation expectations. For an insurance/financial company like MET, lower long-term inflation expectations can compress investment income outlooks and weigh on the stock, providing a plausible macro tailwind for the downside move to continue. However, several factors limit conviction: (1) with 360 minutes remaining the session is effectively just beginning, meaning there is ample time for reversal if the move was driven by an early-session imbalance that gets absorbed; (2) a 2.20% move in MET without a news catalyst could reflect a gap from overnight or early-morning institutional rebalancing that may already be largely complete; (3) no volume data or reversal pattern information is available to confirm sustained selling pressure. The macro backdrop is modestly supportive of continued weakness for a long-duration-sensitive financial name, but the absence of a clear catalyst and the long time horizon reduce certainty. Assigning a modest continuation probability slightly above threshold — the bounded risk profile justifies taking the trade on this lean.
?Jun 22, 10:25 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up 2.08% intraday with no headline catalyst visible, suggesting this is flow-driven or sector-driven buying. With 320 minutes remaining (essentially the full afternoon session), there is ample time for continuation. However, the macro context is mildly headwind for financials/insurers: T5YIE is 1.5σ below trend, meaning inflation expectations are soft, which can compress insurance float yield assumptions and weigh on life insurer sentiment like MET. That said, the absence of news is not disqualifying, and a 2%+ move represents real institutional conviction. No reversal pattern is evident from the data provided. The macro factor creates some caution but not enough to flip below 0.5. Assigning a modest continuation probability reflecting momentum bias tempered by the soft inflation expectations environment.
!Jun 22, 10:25 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MET is up 2.08% intraday with no headline catalyst visible, suggesting this is flow-driven or sector-driven buying. With 320 minutes remaining (essentially the full afternoon session), there is ample time for continuation. However, the macro context is mildly headwind for financials/insurers: T5YIE is 1.5σ below trend, meaning inflation expectations are soft, which can compress insurance float yield assumptions and weigh on life insurer sentiment like MET. That said, the absence of news is not disqualifying, and a 2%+ move represents real institutional conviction. No reversal pattern is evident from the data provided. The macro factor creates some caution but not enough to flip below 0.5. Assigning a modest continuation probability reflecting momentum bias tempered by the soft inflation expectations environment.
▣Jun 14, 8:00 PMjournalstop
options_momentum closed long 100 @ $1.84 (-$29.24)
Stop: premium $1.84 ≤ trailing floor $2.05 (peak $2.74 × 0.75)
▣Jun 14, 8:00 PMjournalstop
options_momentum closed long 40 @ $1.83 (-$11.87)
Stop: premium $1.83 ≤ trailing floor $2.05 (peak $2.74 × 0.75)
▣Jun 14, 8:00 PMjournalstop
options_momentum closed long 100 @ $1.83 (-$90.51)
Stop: premium $1.83 ≤ trailing floor $2.05 (peak $2.74 × 0.75)
✓Jun 12, 11:35 AMdecisionacted
options_momentum — decide: buy
CALL on MET — 5-day return 5.61% with close above 20-day MA ($83.54). IV 22.0%. Sized 1 contract(s) at $2.74 premium.
▣Jun 11, 8:00 PMjournaltarget
options_momentum closed long 60 @ $4.32 (+$131.63)
De-risk: premium $4.32 ≥ 2.0× entry $2.13. Selling 60/200 contracts; trailing the remainder.
▢Jun 11, 8:00 PMjournal
options_momentum opened long 100 @ $2.74
?Jun 10, 10:11 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up ~1.94% today with no headline catalyst, suggesting the move is flow/positioning-driven rather than news-driven. The macro context is slightly headwindy: T10Y2Y at 0.4 is 2.1σ below its 24-month trend, which typically pressures financials/insurers like MET as a flatter/inverted curve compresses net investment income expectations. However, the curve is not deeply inverted — at 0.4 it is flat-to-slightly-positive — so the negative bias is moderate rather than severe. With 335 minutes remaining (roughly a full trading session still ahead), there is ample time for the move to extend, which is a positive for continuation. The 1.94% move is meaningful but sits at the lower bound of the 2-5% 'high conviction' range, so momentum signal is present but not strong. No reversal pattern is evident from the data given. Balancing a modest momentum signal and sufficient time against mild macro sector headwinds for insurers in a flattening curve environment, this is a marginal continuation setup — directional bias is up but with low conviction above the 0.5 threshold.
!Jun 10, 10:11 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MET is up ~1.94% today with no headline catalyst, suggesting the move is flow/positioning-driven rather than news-driven. The macro context is slightly headwindy: T10Y2Y at 0.4 is 2.1σ below its 24-month trend, which typically pressures financials/insurers like MET as a flatter/inverted curve compresses net investment income expectations. However, the curve is not deeply inverted — at 0.4 it is flat-to-slightly-positive — so the negative bias is moderate rather than severe. With 335 minutes remaining (roughly a full trading session still ahead), there is ample time for the move to extend, which is a positive for continuation. The 1.94% move is meaningful but sits at the lower bound of the 2-5% 'high conviction' range, so momentum signal is present but not strong. No reversal pattern is evident from the data given. Balancing a modest momentum signal and sufficient time against mild macro sector headwinds for insurers in a flattening curve environment, this is a marginal continuation setup — directional bias is up but with low conviction above the 0.5 threshold.
✓Jun 10, 9:32 AMdecisionacted
options_momentum — decide: buy
CALL on MET — 5-day return 5.82% with close above 20-day MA ($82.53). IV 21.8%. Sized 2 contract(s) at $2.13 premium.
▢Jun 9, 8:00 PMjournal
options_momentum opened long 60 @ $2.13
▢Jun 9, 8:00 PMjournal
options_momentum opened long 100 @ $2.13
▢Jun 9, 8:00 PMjournal
options_momentum opened long 40 @ $2.13
?May 29, 11:40 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up ~1.93% today with no attributable headline, suggesting real institutional flow rather than a news-driven spike that might fade. The macro context shows T10Y3M at 0.8, printing 1.8σ above its 24-month trend — a steeper yield curve is generally constructive for insurers and financials like MET, as it supports investment income spreads. This provides a mild tailwind to the move. With 245 minutes remaining (well over half the trading day left), there is ample time for continuation. The move is meaningful but not yet at an overextended level (below the 2-5% zone where reversion risk rises sharply). No reversal signals are present in the data provided. The absence of news is not a fade signal per se — this type of quiet, steady grind-up in a macro-supportive environment often reflects position-building. Overall, the balance of evidence supports a modest continuation bias, though without volume confirmation or a clear catalyst, conviction is limited to the lower end of the momentum range.
!May 29, 11:40 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MET is up ~1.93% today with no attributable headline, suggesting real institutional flow rather than a news-driven spike that might fade. The macro context shows T10Y3M at 0.8, printing 1.8σ above its 24-month trend — a steeper yield curve is generally constructive for insurers and financials like MET, as it supports investment income spreads. This provides a mild tailwind to the move. With 245 minutes remaining (well over half the trading day left), there is ample time for continuation. The move is meaningful but not yet at an overextended level (below the 2-5% zone where reversion risk rises sharply). No reversal signals are present in the data provided. The absence of news is not a fade signal per se — this type of quiet, steady grind-up in a macro-supportive environment often reflects position-building. Overall, the balance of evidence supports a modest continuation bias, though without volume confirmation or a clear catalyst, conviction is limited to the lower end of the momentum range.
▣May 26, 8:00 PMjournalmanual
options_momentum closed long 300 @ $3.46 (+$601.47)
Stop: premium $2.07 ≤ trailing floor $2.17 (peak $2.89 × 0.75)
?May 21, 2:55 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up 1.56% intraday, a moderate move suggesting real buying flow but not an extreme momentum surge. As an insurance/financial sector name, MET has some sensitivity to interest rate dynamics. The macro context shows T10YIE at 2.44, elevated 1.7σ above trend — higher inflation expectations can be a mixed signal for insurers: rising rates can benefit investment income (positive for MET) but also pressure long-duration liabilities. No news headlines are present, so the move appears to be driven by broader market or sector flow rather than a company-specific catalyst. With only 50 minutes remaining until the forced close, there is limited runway for the move to extend materially. The 1.56% move is meaningful but not in the 2-5% range that would signal exceptional conviction. Balancing the supportive rate environment for insurers against the limited time remaining and absence of a clear catalyst, this is a borderline read — momentum is real but continuation pressure is not compelling. Assigning a neutral 0.5 reflecting modest upward bias consistent with the system's default toward action given bounded risk.
!May 21, 2:55 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MET is up 1.56% intraday, a moderate move suggesting real buying flow but not an extreme momentum surge. As an insurance/financial sector name, MET has some sensitivity to interest rate dynamics. The macro context shows T10YIE at 2.44, elevated 1.7σ above trend — higher inflation expectations can be a mixed signal for insurers: rising rates can benefit investment income (positive for MET) but also pressure long-duration liabilities. No news headlines are present, so the move appears to be driven by broader market or sector flow rather than a company-specific catalyst. With only 50 minutes remaining until the forced close, there is limited runway for the move to extend materially. The 1.56% move is meaningful but not in the 2-5% range that would signal exceptional conviction. Balancing the supportive rate environment for insurers against the limited time remaining and absence of a clear catalyst, this is a borderline read — momentum is real but continuation pressure is not compelling. Assigning a neutral 0.5 reflecting modest upward bias consistent with the system's default toward action given bounded risk.
?May 21, 9:06 AMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up 1.78% today, a moderate but real move suggesting meaningful buying interest. No headlines are present, which is neutral — not a disqualifier. The macro context shows T10YIE elevated at 1.7σ above trend, indicating inflation expectations are firm. MET as a large-cap insurer/financial benefits modestly from higher rates and steeper yield curves, so the macro backdrop is mildly supportive rather than headwind. However, the move is sub-2%, not a high-conviction breakout, and there is no identifiable catalyst to sustain further momentum. With 400 minutes remaining (well past close — this appears to be a full remaining session or an early-session read), time is ample. Absent any fade signal, reversal pattern, or macro headwind specific to MET, ordinary momentum bias favors continuation at a modest level. Assigning 0.53 — slight lean toward continuation with no strong reason to fade.
!May 21, 9:06 AMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MET is up 1.78% today, a moderate but real move suggesting meaningful buying interest. No headlines are present, which is neutral — not a disqualifier. The macro context shows T10YIE elevated at 1.7σ above trend, indicating inflation expectations are firm. MET as a large-cap insurer/financial benefits modestly from higher rates and steeper yield curves, so the macro backdrop is mildly supportive rather than headwind. However, the move is sub-2%, not a high-conviction breakout, and there is no identifiable catalyst to sustain further momentum. With 400 minutes remaining (well past close — this appears to be a full remaining session or an early-session read), time is ample. Absent any fade signal, reversal pattern, or macro headwind specific to MET, ordinary momentum bias favors continuation at a modest level. Assigning 0.53 — slight lean toward continuation with no strong reason to fade.
✓May 21, 7:01 AMdecisionacted
options_momentum — decide: buy
CALL on MET — 5-day return 5.67% with close above 20-day MA ($79.18). IV 18.6%. Sized 3 contract(s) at $1.87 premium.
▢May 20, 8:00 PMjournal
options_momentum opened long 300 @ $1.45
?May 20, 12:15 PMdecisionconsidered
Agent 7 — Day Trader — decide: skip
MET is up ~1.95% intraday, a meaningful move reflecting real institutional flow. With 210 minutes remaining, there is ample time for continuation. However, the macro context is a headwind: T10YIE at 2.5σ above trend suggests elevated inflation expectations, which puts pressure on long-duration sensitive sectors. Insurance companies like MET are somewhat sensitive to interest rate dynamics — higher inflation expectations can be mixed (higher reinvestment yields are positive, but macro uncertainty and potential rate volatility can weigh). No news catalyst is present to explain the move, which is neutral per the framework. The move magnitude (~2%) is real but not extreme, suggesting momentum without obvious exhaustion. Overall, no strong reason to fade, but macro cross-currents and the absence of a clear catalyst keep conviction moderate. Slight lean toward continuation given bounded downside with the stop structure in place.
!May 20, 12:15 PMsignalseverity 0.02
Agent 7 — Day Trader — day_trade_skipped
MET is up ~1.95% intraday, a meaningful move reflecting real institutional flow. With 210 minutes remaining, there is ample time for continuation. However, the macro context is a headwind: T10YIE at 2.5σ above trend suggests elevated inflation expectations, which puts pressure on long-duration sensitive sectors. Insurance companies like MET are somewhat sensitive to interest rate dynamics — higher inflation expectations can be mixed (higher reinvestment yields are positive, but macro uncertainty and potential rate volatility can weigh). No news catalyst is present to explain the move, which is neutral per the framework. The move magnitude (~2%) is real but not extreme, suggesting momentum without obvious exhaustion. Overall, no strong reason to fade, but macro cross-currents and the absence of a clear catalyst keep conviction moderate. Slight lean toward continuation given bounded downside with the stop structure in place.

← Back to dashboard